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Aim: The low bioavailability of curcumin, a polyphenol, limits its use as an antitumor agent. 
Identifying mechanisms to improve the bioavailability and effectiveness of curcumin can 
modify utilization of other plant-derived phenolic compounds. This study was conducted 
with an aim to determine the influence of some flavonoids on the effects of curcumin in an 
HL-60 cell line. Methods: Cells were incubated in the presence of different concentrations 
of curcumin and several flavonoids for 20 h. Cytotoxicity was evaluated using propidium 
iodide staining. The evaluation of γH2AX expression using a specific antibody, together with 
study of the cell cycle, was analyzed using flow cytometry. Results: A synergistic effect was 
obtained only using a combination of curcumin and lower concentrations of epicatechin. The 
low concentration of quercetin exerted an additive effect only in combination with curcumin. 
Moreover, incubation with curcumin and epicatechin resulted in a significant increase in 
the γH2AX level. Conclusion: Combination treatment with epicatechin and curcumin can 
potentially be considered for improving the effectiveness and bioavailability of curcumin in 
cell lines of myeloid leukemia. 
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INTRODUCTION
Treatment effectiveness in acute myeloid leukemia 
(AML) remains unsatisfactory because of frequent 
relapses and treatment-related problems in elderly 
patients (age > 65), in whom AML incidence is relatively 
high compared to that in younger people[1,2]. Therefore, 
researchers are still on a quest for new, more effective, 
and safer therapies for the treatment of AML, particularly 
in elderly patients in whom aggressive chemotherapy 
for leukemia may sometimes be impossible (e.g. due 
to age-related comorbidities)[1].
Polyphenols are natural phytochemicals, and some 
exhibit a chemopreventive effect as demonstrated 
in vitro and in vivo studies[3-6]. Some polyphenols can 
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METHODS
Reagents
Curcumin (80.1% purity), (-)-epicatechin, quercetin, fetal 
bovine serum (FBS), phosphate-buffered saline (PBS), 
ethanol, formaldehyde, dimethyl sulfoxide (DMSO), 
propidium iodide, and RNAse A were purchased from 
Sigma-Aldrich Co. (St Louis, MO, USA). RPMI 1640 
medium was obtained from American Type Cell Culture 
(ATCC, UK). Primary rabbit monoclonal anti-γH2AX 
(Ser 139) and secondary anti-rabbit IgG (H+L) F(ab′)2 
fragment of goat antibody conjugated with Alexa Fluor 
647 were purchased from Cell Signaling Technology, 
Inc. (Dallas, TX, USA).
HL-60 cell culture and treatment
Cells of the HL-60 line obtained from the American Type 
Culture Collection (ATCC, European branch in UK) 
were cultured in RPMI-1640 medium supplemented 
with 10% FBS without antibiotics at 37 °C in a 5% CO2 
and 95% humidified atmosphere. HL-60 cells were 
incubated in 24-well culture plates (0.4 × 106 cells/
well) with different concentrations of polyphenols or 
combination treatments for 20 h. Polyphenols for 
evaluation were dissolved in DMSO (0.06% in the 
culture medium), whereas control cells were incubated 
only with DMSO.
Measurement of cytotoxicity and 
determination of combination index
Propidium iodide staining was used to determine the 
cytotoxicity of the investigated polyphenols; cells were 
stained according to instructions that were developed 
and optimized by R&D Systems Flow Cytometry 
Laboratory. Briefly, after 24 h of incubation, the cells 
were washed (230 g, 5 min) and resuspended in 100 μL 
PBS; then 10 μL PI staining solution (10 μg/mL) was 
added. Cells were incubated for 1 min in the dark 
and, thereafter, the volume of the PBS was increased 
to 350 μL. The treated cells (at least 20,000 single 
cells) were immediately subjected to flow cytometric 
analysis. The half-maximal inhibitory concentration 
(IC50) and the combination index (CI) for HL-60 cells 
were calculated using CalcuSyn (Biosoft, Cambridge, 
UK). The CI was evaluated by the multiple drug-effect 
equation of Chou-Talalay; CI values less than 1 indicate 
synergism, those equal to 1 indicate an additive effect, 
and values greater than 1 indicate antagonism[28].
Cell staining and analysis for γH2AX and the 
cell cycle
Phosphorylated histone H2AX (γ-H2AX) was detected 
exert a cytotoxic effect in AML cells[7] and curcumin, 
isolated from the rhizome Curcuma longa L. and with 
broad-spectrum anticancer properties, is an example[8]. 
Curcumin not only inhibits multiple pathways on different 
levels that are often overexpressed in cancer cells but also 
sensitizes them to apoptosis; in cancer cells resistant to 
apoptosis, curcumin can induce an alternative cell death, 
such as a mitotic catastrophe[8-10]. Curcumin acts at the 
gene level and triggers many metabolic pathways[11,12]. 
It inhibits genes contributing to multidrug resistance 
and can modulate epigenetic phenomena by inhibiting 
the methyltransferase 1 in AML cells[13,14].
At present, intensive research efforts are directed 
toward leveraging the anticancer effect of curcumin 
and improving its bioavailability[15]. Interest in this 
polyphenol is high, and the number of research efforts 
studying its anticancer activity is steadily increasing[16]. 
Thus, curcumin has a potential role in the development 
of novel cancer treatments.
Curcumin’s significant advantage is its low toxicity. 
Curcumin does not exhibit toxic effects in the human 
body even at doses of 9 g/kg b.w.[17,18]. Unfortunately, a 
major problem in the use of curcumin is its low bioavail-
ability and rapid metabolism in plasma[19]. To improve 
bioavailability and stability of the compound currently 
involves improving the methods for creating micro- 
and nanoparticles of curcumin, liposomes, micelles, 
and derivatives of curcumin[20-23]. The effectiveness of 
curcumin, however, can be potentiated simply by using 
a combination of the compound and other polyphenols. 
This constitutes one of the most natural ways to improve 
the efficiency of curcumin action, and effectively 
increase its bioavailability[24,25].
The use of curcumin in combination with other 
polyphenols may potentiate its effectiveness through 
synergistic interactions[26]. Furthermore, cancer is 
a clonal disease, and individual clones of cells differ 
in sensitivity to chemotherapy and fall in mutual 
interactions[27]. Therefore, therapeutic action directed 
at various molecular targets, such as those exhibited by 
curcumin, may be more effective than action directed 
towards only one of these targets. Combination 
therapy of curcumin with other polyphenols that act 
synergistically with curcumin may be an effective and 
safe addition to conventional chemotherapy, and may 
allow dose reduction of cytostatic drugs.
This preliminary study was conducted to investigate 
the influence of a several flavonoid polyphenols on the 
cytogenotoxic activity of curcumin in a HL-60 myeloid 
leukemia cell line.
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wherein its mode of action depends closely on their 
concentrations. Lower concentrations of epicatechin in 
the range of 50-500 µmol/L synergistically intensified 
cytotoxic effects of curcumin (CI < 1, Figure 2C and 
D), whereas high concentrations (750 µmol/L and 1 
mmol/L) acted antagonistically with curcumin (CI > 1, 
Figure 2C and D). The biological significance of this 
synergism can only be expected with the combination 
of C10/C20 + EC500 µmol/L, whose cytotoxic effect is 
significant in comparison to curcumin [Figure 2A and B].
Quercetin exerted an additive effect only at the lowest 
applied concentration (5 µmol/L with 20 µmol/L 
curcumin, CI = 1, Figure 3C), but the difference between 
these groups was not significant [Figure 3B]. Higher 
concentrations of quercetin in the range of 20-100 µmol/L 
acted antagonistically with curcumin (CI > 1, Figure 3C).
Effect of polyphenols combinations on the 
level of phosphorylated H2AX and cell cycle
None of the investigated polyphenols had a significant 
effect on the level of γH2AX after 20-h incubation 
[Figure 4A]. The combination of curcumin 40 µmol/L 
and epicatechin 500 µmol/L significantly potentiated 
H2AX phosphorylation in comparison with controls 
[Figure 4A and B], suggesting that this combined effect 
induces DSBs.
Among the investigated compounds, the strongest 
influence on the cell cycle was exerted by curcumin, 
which inhibited the cell cycle in the S phase, as 
evidenced by a significant increase in the percentage 
of cells in this phase of the cell cycle after curcumin 
treatment of HL-60 cells compared to the control (P < 
0.05, Table 1). Consequently, curcumin significantly 
decreased the percentage of cells in the G1 and G2/M 
phases as compared to the control (P < 0.05, Table 1). 
Quercetin, among the polyphenols tested, exhibited 
as a marker of DNA damage, mainly double-DNA 
strand breaks (DSBs). Briefly, the cells were fixed on 
ice with 1% methanol-free formaldehyde solution in 
PBS for 15 min and permeabilized with ice-cold 70% 
ethanol diluted in deionized water and added dropwise 
to the cells with stirring. The cells were incubated with 
ethanol for 24 h at -20 °C and then washed twice with 
1% BSA in PBS. Next, HL-60 cells (0.4 × 106/well) 
were stained with primary rabbit monoclonal anti-γ-
H2AX (Ser139) antibody for 2 h at room temperature, 
subsequently washed twice with 1% BSA in PBS, 
and then incubated with a secondary anti-rabbit 
immunoglobulin (Ig) G (H+L) F(ab′)2 fragment of goat 
antibody conjugated with Alexa Fluor 647 for 30 min in 
the dark. Next, the cells were washed twice with 1% 
BSA in PBS. DNA was stained with PI and RNase A 
in PBS for 30 min at room temperature in the dark. An 
isotype control was set with the rabbit monoclonal IgG 
XP antibody. Then, cells were analyzed with a LSRII 
flow cytometer using red and blue lasers and 633-nm 
excitation for Alexa Fluor 647 (660/20 BP filter) and 
488-nm excitation for PI/PE (575/26 BP filter). Cell 
doublets and debris were excluded from analysis using 
PI-width versus PI-area calculations, and at least 
20,000 single cells were analyzed using an LSR II flow 
cytometer; quantitative analysis of γ-H2AX-positive 
cells was conducted using FACSDiva software (BD 
Biosciences Immunocytometry Systems).
Statistical analysis
Test U Mann-Whitney and one-way analysis of 
variance (ANOVA) with the Tukey post hoc test were 
used to calculate the statistical significance between 
groups. All data are shown as mean ± standard error 
of the mean.
RESULTS
Analysis of cytotoxicity of investigated 
polyphenols and their combinations
The cytotoxic effects of investigated polyphenols 
were dependent on their concentrations. Among the 
tested polyphenols, curcumin exerted the most potent 
cytotoxic action in cells. This polyphenol was already 
cytotoxic at a concentration of 10 µmol/L (P < 0.001) 
as compared with the control [Figure 1]. In general, 
the investigated polyphenols can be sequentially 
ranked by cytotoxic activity as: curcumin > quercetin > 
epicatechin [Figures 1-3].
Each flavonoid in the study modified curcumin cytotoxic 
activity in HL-60 cells but in different ways. CI analysis 
showed that epicatechin most strongly modified 
the effect of curcumin among the tested flavonoids, 
Figure 1: The cytotoxicity induced by curcumin in HL-60 cells after 
20 h of incubations. Cytotoxicity was investigated by using propidium 
iodide staining and analyzed in flow cytometer. Values are means ± 
SEM, **P < 0.01, ***P < 0.001 vs. control (Mann-Whitney test). 
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Figure 2: The influence of epicatechin on cytotoxic effect of curcumin in HL-60 cells. Cells were incubated with increased concentrations of 
epicatechin (A) and/or curcumin in concentration of 10 (A) or 20 μmol/L (B) for 20 h. Control cells were incubated with DMSO only. Cytotoxicity 
was investigated by using propidium iodide staining and analyzed in flow cytometer. Interaction between investigated compounds was analyzed 
by Calcusyn software separately for Cur10 μmol/L + EC 50 μmol/L - 1 mmol/L (C) and for Cur20 μmol/L + EC 50 μmol/L - 1 mmol/L (D). The 
lower concentrations of epicatechin (50-500 μmol/L) cooperated synergistically with curcumin (CI < 1) increasing cytotoxic effect (C) and (D). 
However high concentrations of epicatechin (750 μmol/L and 1 mmol/L) exerted antagonistic effect with curcumin (CI > 1, (C) and (D)), because 
their effect together with curcumin was less than the sum of the individual components in these concentrations. Values are means ± SEM, *P < 
0.05, **P < 0.01, ***P < 0.001; vs. control; #P < 0.05, ##P < 0.01, ###P < 0.001 vs. Cur; ++P < 0.01 vs. EC500; P = 0.07 vs. Cur. (Mann-Whitney test). 
Cur: curcumin; EC: epicatechin; CI: combination index, × combination of investigated compounds
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which are ubiquitous in edible plants, can variably 
modify curcumin cytotoxicity based on their therapeutic 
concentration in AML cell lines. In our own earlier 
studies, we have demonstrated a cytotoxic effect of 
curcumin in HL-60 cells that was mediated through a 
free-radical mechanism, because the use of N-acetyl-
l-cysteine was protective against the cytotoxic effect of 
curcumin[29].
Because polyphenols may be characterized by the 
opposite anti- or pro-oxidant activity, depending on the 
microenvironment of the cell[30-32], it may be assumed 
that both quercetin and epicatechin can modify 
the action of curcumin by affecting the oxidative 
the weakest effect on the cell cycle, significantly 
reducing the percentage of cells in phase G1 (P < 
0.05, Table 1). Epicatechin induced a significant 
decrease in the percentage of cells in the S and G2/M 
phases [Table 1], indicating its potential for strong 
cytotoxic activity. The strongest effect on the level of 
sub-G1 apoptotic fraction was exerted by curcumin 
and epicatechin. The flavonoids we investigated did 
not significantly modify the effect of curcumin on cell 
cycle in HL-60 cells (data not shown).
DISCUSSION
Polyphenols, such as quercetin and epicatechin and 
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state. In addition, HL-60 cells are characterized by 
high myeloperoxidase (MPO) activity. Polyphenols 
comprising a catechol group, such as epicatechin or 
quercetin[33], or with a β-diketone structure, such as 
curcumin[34], may exert a prooxidative effect, increase 
the production of 8-hydroxy-2’deoxyguanosine (8-
OHdG), and induce apoptosis in the presence of 
elevated Cu2+ concentration, as is the case in cancer 
cells[34-36]. Polyphenols reduce Cu2+ to Cu+ ions, which 
then react with oxygen to contribute to an increase in 
H2O2, which is essential for the induction of apoptosis 
by MPO[37]. Furthermore, MPO activity is high in HL-60 
cells[37]. Khan et al.[38] found that the use of neocuproine, 
a chelator of Cu2+ ions, inhibits polyphenol-induced 
apoptosis in cancer cell lines.
In the present study, epicatechin most effectively 
increased the cytotoxic effect of curcumin - a synergistic 
effect of both compounds that was not observed in 
combination with other polyphenols and curcumin. 
Previous studies have demonstrated that epicatechin is 
subject to single-electron oxidation, with MPO activity 
leading to increased H2O2 production, with a resultant 
increase in the level of DNA damage in HL-60 cells[35]. 
In other studies, epicatechin was shown to be a very 
good electron donor for various heme peroxidases 
and was preferentially oxidized in the presence of 
other substrates of MPO[39]. Considering these facts, 
epicatechin can potentiate curcumin cytotoxicity in HL-
60 cells through a free-radical mechanism. However, 
epicatechin potentiated the effect of curcumin at lower 
concentrations, whereas high concentrations of the 
flavonoid acted antagonistically with curcumin. Our 
results are consistent with those reported from other 
studies of cytotoxic effects from a combination of 
different polyphenols, which often depend on the type 
of interaction and concentration of compounds[26].
Among the investigated polyphenols, epicatechin 
has been identified as a potential candidate for 
further research to improve curcumin cytotoxicity 
in vivo because the compound acts synergistically 
with curcumin. This synergistic effect of epicatechin 
and curcumin was also observed by Saha et al.[40] 
in human lung carcinoma PC-9 and A549 cell lines. 
Figure 3: The influence of quercetin on cytotoxic effect of curcumin 
in HL-60 cells. Cells were incubated with curcumin in concentration 
of 10 (A) or 20 μmol/L (B) and/or increased concentrations of 
quercetin for 20 h. Cytotoxicity was investigated by using propidium 
iodide staining and analyzed in flow cytometer. Interaction between 
investigated compounds was analyzed by Calcusyn software (C). 
Quercetin increased significantly the cytotoxic effect of curcumin at 
the concentrations of 20-100 μmol/L (A) and (B) but the interactions 
between these two compounds were mostly antagonistic. For most 
combinations, the value of the combination index (CI) was greater 
than 1 (C). However quercetin at concentrations of 5 μmol/L induced 
additive effect with 20 μmol/L of curcumin (CI = 1), (C) but the effect of 
this two compounds was not significant compared to curcumin alone. 
Values are means ± SEM, *P < 0.05, **P < 0.01, ***P < 0.001 vs. 
control; ###P < 0.001 vs. Cur; ++P < 0.01, +++P < 0.001 vs. appropriate 
Q group (Mann-Whitney test). Cur: curcumin; Q: quercetin; CI: 
combination index, × combination of investigated compounds
Group Sub-G1 fraction G1 phase S phase G2/M phase
Control 9.92 ± 2.51 54.04 ± 1.34 21.87 ± 0.95 13.20 ± 0.62
C40 (μmol/L) 23.97 ± 1.31* 22.55 ± 1.24* 42.62 ± 1.88* 7.85 ± 1.07*
Q50 (μmol/L) 27.37 ± 7.27 42.02 ± 4.98* 18.87 ± 1.88 8.25 ± 2.13
EC500 (μmol/L) 39.87 ± 10.12* 39.30 ± 7.08 16.00 ± 1.43* 4.37 ± 1.01*
Table 1: The influence of investigated polyphenols on cell cycle of HL-60 cells after 20 h of incubation
Curcumin significantly arrested cell cycle at S phase (P < 0.05). C: curcumin, Q: quercetin, EC: epicatechin. *P < 0.05. Values are means ± 
SEM, *P < 0.05 vs. control (Mann-Whitey test)
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Epicatechin potentiated the inhibition of growth and 
apoptosis induced by curcumin in these cells. The 
authors suggest this synergism is responsible for the 
increased curcumin bioavailability when administered 
in combination with epicatechin, because they showed 
increase in intracellular concentrations of curcumin 
in cells incubated simultaneously with epicatechin[40]. 
Similarly, Ghosh et al.[41] showed that curcumin and 
epigallocatechin gallate (EGCG), when sequentially 
added to the medium, act synergistically in chronic 
lymphocytic leukemia (CLL) cells.
We gathered interesting data by analyzing the levels 
of phosphorylated H2AX -- a marker of DNA DSBs. 
The investigated polyphenols did not increase 
phosphorylation of H2AX even at concentrations 
that caused significant cytotoxicity. In contrast, a 
combination of curcumin and epicatechin significantly 
increased the level of γH2AX. Therefore, the increase 
in genotoxicity induced by a combination of polyphenols 
underlies their cytotoxic activity in HL-60 cells. This 
effect is interesting because such genotoxicity is 
characteristic of conventional cytostatic drugs. Further 
research should be designed to evaluate whether 
the combination of curcumin and epicatechin induce 
genotoxic effects in normal cells. However, considering 
that many studies confirm a more selective cytotoxic 
effect of polyphenols in cancer cells as compared to 
conventional anticancer drugs[42], the combination of 
curcumin and epicatechin will have a dual cytogenotoxic 
impact in leukemic cells but a weaker effect in normal 
cells. In addition, we have observed such selective 
genotoxic activity of epicatechin in leukemic cells as 
compared to normal cells, in our comparative research 
Figure 4: The influence of the polyphenols in this study and their combinations on the level of γ-H2AX in HL-60 cells after 20 h of incubation. (A) 
The level of fluorescence intensity of γ-H2AX measured by flow cytometry; (B) representative dot plots of γ-H2AX vs. DNA staining. Curcumin, 
quercetin and epicatechin did not influence the level of γ-H2AX at the investigated concentrations (A). However the combination of epicatechin 
(500 μmol/L) and curcumin (40 μmol/L) increased significantly the level of phosphorylated H2AX (A), (B). Values are means ± SEM, *P < 0.05 vs. 
control, #P < 0.05 vs. C40 (ANOVA, Tukey post hoc test). Cur: curcumin; Q: quercetin; EC: epicatechin; RFU: relative fluorescence units.
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study in a acute myeloid leukemia BNML rat model 
and healthy rats of the same line[43].
In our experiments only epicatechin potentiated 
the phosphorylation of H2AX in combination 
with curcumin. Simultaneous treatment of HL-60 
cells with quercetin and curcumin did not exert a 
significant genotoxic effect. Thus, the mechanism 
of action of the latter combination of polyphenols is 
different from the combined effect of curcumin and 
epicatechin. Although these studies used relatively 
high concentrations of polyphenols, it cannot be 
overlooked that they will work similarly in vivo. Findings 
have shown that high concentrations of polyphenols 
during short in vitro incubation periods induce effects 
similar to those attained in long-term cell cultures in 
the presence of low concentrations of polyphenols 
that have been detected in body fluids[44]. Given the 
fact that the type of interaction between polyphenols is 
multifactorial, including not only the structure but also 
drug concentration and cell microenvironment, caution 
is required with using supplementation complexes of 
polyphenols, as their effects may be difficult to predict. 
From the results obtained, a combination of curcumin 
and epicatechin may be the subject of further study 
in animal models to determine doses that can exert 
significant effects in leukemia cells in vivo.
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